[
    [
        {
            "time": "2023-10-14",
            "original_text": "【民生医药|周报】10/14：生物药和外包板块表现优异，关注业绩高增长标的",
            "features": {
                "keywords": [
                    "生物药",
                    "外包板块",
                    "业绩高增长",
                    "标的"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物药",
                    "外包服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|周报】10/14：生物药和外包板块表现优异，关注业绩高增长标的",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]